[EN] IMIDAZOPYRIDINE AND OXAZOLOPYRIDINE DERIVATIVES AND ANALOGS THEREOF, METHODS OF PREPARATION THEREOF, METHODS OF HIF-1/2A PATHWAY INHIBITION, AND INDUCTION OF FERROPTOSIS [FR] DÉRIVÉS D'IMIDAZOPYRIDINE ET D'OXAZOLOPYRIDINE ET LEURS ANALOGUES, LEURS PROCÉDÉS DE PRÉPARATION, PROCÉDÉS D'INHIBITION DE LA VOIE HIF-1/2A ET INDUCTION DE LA FERROPTOSE
摘要:
Novel substituted imidazopyridine and oxazolopyridine compounds that are useful as inhibitors of HIF-1α and HIF-2α and inducers of ferroptosis through perturbations in iron metabolism, synthetic methods for making said compounds, pharmaceutical compositions comprising the compounds, and methods of using the compounds and compositions to treat disorders associated with dysfunction of HIF-1/2α or iron metabolism.
[EN] IMIDAZOPYRIDINE AND OXAZOLOPYRIDINE DERIVATIVES AND ANALOGS THEREOF, METHODS OF PREPARATION THEREOF, METHODS OF HIF-1/2A PATHWAY INHIBITION, AND INDUCTION OF FERROPTOSIS [FR] DÉRIVÉS D'IMIDAZOPYRIDINE ET D'OXAZOLOPYRIDINE ET LEURS ANALOGUES, LEURS PROCÉDÉS DE PRÉPARATION, PROCÉDÉS D'INHIBITION DE LA VOIE HIF-1/2A ET INDUCTION DE LA FERROPTOSE
摘要:
Novel substituted imidazopyridine and oxazolopyridine compounds that are useful as inhibitors of HIF-1α and HIF-2α and inducers of ferroptosis through perturbations in iron metabolism, synthetic methods for making said compounds, pharmaceutical compositions comprising the compounds, and methods of using the compounds and compositions to treat disorders associated with dysfunction of HIF-1/2α or iron metabolism.
[EN] IMIDAZOPYRIDINE AND OXAZOLOPYRIDINE DERIVATIVES AND ANALOGS THEREOF, METHODS OF PREPARATION THEREOF, METHODS OF HIF-1/2A PATHWAY INHIBITION, AND INDUCTION OF FERROPTOSIS<br/>[FR] DÉRIVÉS D'IMIDAZOPYRIDINE ET D'OXAZOLOPYRIDINE ET LEURS ANALOGUES, LEURS PROCÉDÉS DE PRÉPARATION, PROCÉDÉS D'INHIBITION DE LA VOIE HIF-1/2A ET INDUCTION DE LA FERROPTOSE
申请人:[en]KUDA THERAPEUTICS, INC.
公开号:WO2023234970A1
公开(公告)日:2023-12-07
Novel substituted imidazopyridine and oxazolopyridine compounds that are useful as inhibitors of HIF-1α and HIF-2α and inducers of ferroptosis through perturbations in iron metabolism, synthetic methods for making said compounds, pharmaceutical compositions comprising the compounds, and methods of using the compounds and compositions to treat disorders associated with dysfunction of HIF-1/2α or iron metabolism.